Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
With
Vicuron Pharmaceuticals
Anidulafungin is an investigational drug being developed as an intravenous treatment for esophageal candidiasis, candidemia and other invasive fungal infections. Anidulafungin is an antifungal agent of the echinocandin class, which targets the fungal cell wall of yeast and other filamentous fungi.
Age
2–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children ages 2-17 years with fever and neutropenia.
The expected duration of neutropenia should be 10 days and due to cytotoxic chemotherapy or aplastic anemia.
Clareo Health | Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
